ArticleJAMA oncology2018
Estimating and Interpreting the Overall Survival Benefit of Checkpoint Inhibitors via Meta-analysis-Reply.
Val Gebski et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papertrialcites it
ArticleJAMA oncology2018
Val Gebski et al.PubMed ↗Publisher ↗
No numbers read from the abstract.